Plasma 25-Hydroxyvitamin D and Its Genetic Determinants in Relation to Incident Myocardial Infarction and Stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kühn, Tilman ^a   Kaaks, Rudolf ^a   Teucher, Birgit ^a   Hirche, Frank ^b   Dierkes, Jutta ^c   Weikert, Cornelia ^d   Katzke, Verena ^a   Boeing, Heiner ^d   Stangl, Gabriele I ^b   Buijsse, Brian ^d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF BERGEN   (Norway)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE STUDY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN; VITAMIN BLOOD LEVEL;

ADULT; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; STEROID HYDROXYLASES; STROKE; TANDEM MASS SPECTROMETRY; VITAMIN D;

EID: 84880778564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069080     Document Type: Article

References (49)

1. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, et al. (2012) The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33: 456-492. doi:10.1210/er.2012-1000. PubMed: 22596255.
2. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281. doi:10.1056/NEJMra070553. PubMed: 17634462.
3. Norman AW, Bouillon R, (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 235: 1034-1045. doi:10.1258/ebm.2010.010014.
4. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ, (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-210. PubMed: 12499343.
5. Van der Schueren BJ, Verstuyf A, Mathieu C, (2012) Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol 23: 17-23. doi:10.1097/MOL.0b013e32834d7357. PubMed: 22123672.
6. Motiwala SR, Wang TJ, (2011) Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens 20: 345-353. doi:10.1097/MNH.0b013e3283474985. PubMed: 21519252.
7. Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F, et al. (2012) Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLOS ONE 7: e35316. doi:10.1371/journal.pone.0035316. PubMed: 22536373.
8. Brandenburg VM, Vervloet MG, Marx N, (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225: 253-263. doi:10.1016/j.atherosclerosis.2012.08.005. PubMed: 22921424.
9. Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM, (2012) 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43: 1470-1477. doi:10.1161/STROKEAHA.111.636910. PubMed: 22442173.
10. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG, (2012) 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 32: 2794-2802. doi:10.1161/ATVBAHA.112.248039. PubMed: 22936341.
11. Institute of Medicine (US) Committee to Review Dietary Reference. Intakes for Vitamin D and Calcium (2011) Dietary Reference Intakes for Calcium and Vitamin D. Washington: The National Academies Press. 9780309163941 9780309163941.
12. McGreevy C, Williams D, (2011) New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 155: 820-826. doi:10.7326/0003-4819-155-12-201112200-00004. PubMed: 22184689.
13. Kupferschmidt K, (2012) Uncertain verdict as vitamin D goes on trial. Science 337: 1476-1478. doi:10.1126/science.337.6101.1476. PubMed: 22997323.
14. Zittermann A, Börgermann J, Gummert JF, Pilz S, (2012) Future directions in vitamin D and cardiovascular research. Nutr Metab Cardiovasc Dis 22: 541-546. doi:10.1016/j.numecd.2012.02.004. PubMed: 22633567.
15. Pilz S, Rutters F, Dekker JM, (2012) Disease prevention: vitamin D trials. Science 338: 883. doi:10.1126/science.338.6109.883-b. PubMed: 23161977.
16. Berry DJ, Vimaleswaran KS, Whittaker JC, Hingorani AD, Hyppönen E, (2012) Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLOS ONE 7: e37465. doi:10.1371/journal.pone.0037465. PubMed: 22629401.
17. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, et al. (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19: 2739-2745. doi:10.1093/hmg/ddq155. PubMed: 20418485.
18. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180-188. doi:10.1016/S0140-6736(10)60588-0. PubMed: 20541252.
19. Sheehan NA, Didelez V, Burton PR, Tobin MD, (2008) Mendelian randomisation and causal inference in observational epidemiology. PLOS Med 5: e177. doi:10.1371/journal.pmed.0050177. PubMed: 18752343.
20. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, et al. (2012) Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromso Study. PLOS ONE 7: e37295. doi:10.1371/journal.pone.0037295. PubMed: 22649517.
21. Boeing H, Wahrendorf J, Becker N, (1999) EPIC-Germany--A source for studies into diet and risk of chronic diseases. Eur Investig Into Cancer Nutr. Ann Nutr Metab 43: 195-204.
22. Bergmann MM, Bussas U, Boeing H, (1999) Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 225-234. doi:10.1159/000012789. PubMed: 10592371.
23. Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K, (2007) Case-cohort design in practice- experiences from the MORGAM Project. Epidemiol Perspect Innov 4: 15. doi:10.1186/1742-5573-4-15. PubMed: 18053196.
24. Prentice RL, (1986) A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73: 1-11. doi:10.1093/biomet/73.1.1.
25. Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, et al. (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54: 2272-2282. doi:10.1007/s00125-011-2182-9. PubMed: 21717116.
26. McGrath JJ, Saha S, Burne TH, Eyles DW, (2010) A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 121: 471-477. doi:10.1016/j.jsbmb.2010.03.073. PubMed: 20363324.
27. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, et al. (2008) Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100: 796-804. doi:10.1093/jnci/djn152. PubMed: 18505967.
28. Borkowf CB, Albert PS, Abnet CC, (2003) Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories. Stat Med 22: 1477-1493. doi:10.1002/sim.1507. PubMed: 12704611.
29. Website of the Robert Koch Institute. Available in German:http://www.rki.de/SharedDocs/FAQ/vitamind3/vitamind3.html?nn=2444038#FAQId2437556 Accessed 2013.
30. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, et al. (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6: 407-413. PubMed: 12795830.
31. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P, (2006) Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs. Comput Statist Data Anal 50: 3464-3485. doi:10.1016/j.csda.2005.07.015.
32. Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, et al. (2012) A global representation of vitamin D status in healthy populations. Arch Osteoporos 7: 155-172. doi:10.1007/s11657-012-0093-0. PubMed: 23225293.
33. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, et al. (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21: 1121-1132. doi:10.1007/s00198-009-1119-3. PubMed: 19957164.
34. Giovannucci E, Liu Y, Hollis BW, Rimm EB, (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180. doi:10.1001/archinte.168.11.1174. PubMed: 18541825.
35. Welsh P, Doolin O, McConnachie A, Boulton E, McNeil G, et al. (2012) Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. J Clin Endocrinol Metab 97: 4578-4587. doi:10.1210/jc.2012-2272. PubMed: 23071162.
36. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, et al. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106: 963-968. doi:10.1016/j.amjcard.2010.05.027. PubMed: 20854958.
37. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, et al. (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58: 1433-1441. doi:10.1016/j.jacc.2011.03.069. PubMed: 21939825.
38. Karakas M, Thorand B, Zierer A, Huth C, Meisinger C, et al. (2013) Low Levels of Serum 25-Hydroxyvitamin D Are Associated with Increased Risk of Myocardial Infarction, Especially in Women: Results from the MONICA/KORA Augsburg Case-Cohort Study. J Clin Endocrinol Metab 98: 272-280. doi:10.1210/jc.2012-2368. PubMed: 23150690.
39. Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, et al. (2013) Exploring the genetic architecture of circulating 25-hydroxyvitamin D. Genet Epidemiol 37: 92-98. doi:10.1002/gepi.21694. PubMed: 23135809.
40. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, et al. (2013) Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts. PLOS Med 10: e1001383. PubMed: 23393431.
41. Trummer O, Pilz S, Hoffmann MM, Winkelmann BR, Boehm BO, et al. (2013) Vitamin D and mortality: a Mendelian randomization study. Clin Chem 59: 793-797. doi:10.1373/clinchem.2012.193185. PubMed: 23319826.
42. Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, et al. (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 19: 938-946. doi:10.1158/1055-9965.EPI-09-1318. PubMed: 20332276.
43. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E, (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15: 255-265. doi:10.1023/B:CACO.0000024245.24880.8a. PubMed: 15090720.
44. Sonderman JS, Munro HM, Blot WJ, Signorello LB, (2012) Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol 176: 615-621. doi:10.1093/aje/kws141. PubMed: 22975199.
45. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171: 903-908. doi:10.1093/aje/kwq005. PubMed: 20219763.
46. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, et al. (2012) Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 72: 1190-1198. doi:10.1158/1538-7445.AM2012-1190. PubMed: 22232734.
47. Mondul AM, Weinstein SJ, Virtamo J, Albanes D, (2012) Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer 107: 1589-1594. doi:10.1038/bjc.2012.417. PubMed: 22990651.
48. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, et al. (2013) Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer 132: 2940-2947. doi:10.1002/ijc.27969. PubMed: 23180681.
49. Chun RF, (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30: 445-456. doi:10.1002/cbf.2835. PubMed: 22528806.